Reckitt to pay $1.4bn in opioid addiction treatment settlement

Reckitt Benckiser will pay $1.4bn to resolve investigations by the US Department of Justice and the Federal Trade Commission into how its former subsidiary marketed Suboxone, a drug used to treat opioid addiction.